ESTUDIO OBSERVACIONAL RETROSPECTIVO DE VALIDACIÓN DE LA "ART SCORE", PARA LA EVALUACIÓN DEL RETRATAMIENTO CON QUIMIOEMBOLIZACIÓN TRANSARTERIAL EN PACIENTES CON CARCINOMA HEPATOCELULAR. ESTUDIO DALIA.

A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond

Gomez-Martin, C; (...); Lordick, F

Review. 10.1016/j.canlet.2014.05.019. 2014

• 
• 59

  

Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer

Feliu, J; (...); Maurel, J

Article. 10.1371/journal.pone.0116527. 2015

• 
• 
• 43

  

Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer

Bruixola G; (...); Santaballa A

Article. 10.1097/IGC.0000000000000330. 2015

• 
• 5

  

First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

Feliu, J; (...); Maurel, J

Article. 10.1038/bjc.2014.346. 2014

• 30

  

Guidelines for diagnosis, staging and treatment of metastatic colorectal cancer by Grupo Espanol Multidisciplinar en Cancer Digestivo (GEMCAD)

Aguilar, G; (...); Zorrilla, M

Review. 10.2217/CRC.15.9. 2015

Heart failure as first sign of development of cardiac metastases in a patient with diagnosis of papillary thyroid carcinoma on treatment with tyrosine-kinase inhibitors: differential diagnoses and clinical management.

Bruixola G; (...); Díaz-Beveridge R

Article. 10.1159/000366192. 2014

• 2

  

Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine

Murria R; (...); Bolufer P

Article. 2015

Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer

Murria R; (...); Bolufer P

Article. 2015

New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis

Valle, L; (...); Blanco, I

Article. 10.1093/hmg/ddu058. 2014

• 
• 138

  

Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant Chemotherapy

Custodio, A; (...); Feliu, J

Article. 10.1158/1535-7163.MCT-13-1109. 2014

• 10

  

Pleuropulmonary angiosarcoma involving the liver, the jejunum and the spine, developed from chronic tuberculosis pyothorax: Multidisciplinary approach and review of literature

Bruixola G; (...); Aparicio J

Review. 10.1016/j.lungcan.2014.07.012. 2014

• 
• 4

  

Preoperative Chemotherapy in Patients With Intermediate-Risk Rectal Adenocarcinoma Selected by High-Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Trial

Fernandez-Martos, C; (...); Pericay, C

Editorial Material. 10.1634/theoncologist.2014-0233. 2014

• 
• 68

  

Prevalence of germline MUTYH mutations among Lynch-like syndrome patients

Castillejo A; (...); Soto JL

Article. 10.1016/j.ejca.2014.05.022. 2014

• 
• 70

  

Primary Mesenteric Undifferentiated Pleomorphic Sarcoma Masquerading as a Colon Carcinoma: A Case Report and Review of the Literature.

Diaz-Beveridge R; (...); Aparicio J

Article. 10.1155/2015/532656. 2015

• 12

  

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Aparicio J; (...); Germà JR

Article. 10.1093/annonc/mdu437. 2014

• 
• 111

  

Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience

Imedio ER; (...); Salcedo JM

Article. 10.1007/s12032-014-0948-x. 2014

• 8

  

Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base

Girones, R; (...); SGCCG

Article. 10.1007/s12094-014-1179-5. 2014

• 
• 17